en

PRODUCT DETAIL

Tremfya 200 mg koncentrát na infúzny roztok

Code 0133F
MA number EU/1/17/1234/005
Product Form: con inf 1x20 ml/200 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Janssen - Cilag International N.V., Belgium
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AC Interleukin inhibitors
L04AC16 Guselkumab
Shelf life: 24
Container: pre-filled syringe
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 10.11.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 28.05.2025
eu-flag.png sk-flag.png